Cholesterol-lowering statin drugs may slow down prostate cancer in men who are also taking medication to reduce their levels of male hormones, according to new research. Lauren Harshman, assistant professor of medicine at Dana-Farber Cancer Institute, is the study’s lead author.
Trending News
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure
Rare Inherited Genetic Mutation Is One of Strongest Indicators Yet for Lung Cancer Risk
Influence of EGFR variant could expand screening guidelines
‘Molecular Movie’ Fills in Blanks of How Non-Enveloped Viruses Infect Cells
Cryo-ET of rotavirus answers decades-old virology question, could inform drug delivery techniques